Omeros (OMER) Interest Expenses (2010 - 2026)
Omeros' (OMER) quarterly Interest Expenses came in at $5.9 million in Q1 2026, up 61.3% year-on-year from $3.7 million in Q1 2025, and down 32.45% quarter-over-quarter from $8.7 million in Q4 2025.
Omeros (OMER) Interest Expenses (2010 - 2026) Analysis & Trends
Omeros has disclosed Interest Expenses across 17 years of filings, most recently posting $5.9 million for Q1 2026.
- Interest Expenses for Q1 2026 came in at $5.9 million, up 61.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (down 93.63% YoY), and the FY2025 annual result was -$960000.0, down 292.0% from the prior year.
- Interest Expenses came in at $5.9 million for Q1 2026 at Omeros, down from $8.7 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $9.2 million in Q2 2024 to a low of -$13.4 million in Q3 2025.
- The 5-year median for Interest Expenses is $5.9 million (2026), against an average of $4.9 million.
- Peak annual rise in Interest Expenses reached 174.66% in 2025, while the deepest fall reached 429.59% in 2025.
- Omeros' Interest Expenses stood at $7.9 million in 2022, then decreased by 10.63% to $7.1 million in 2023, then slumped by 55.02% to $3.2 million in 2024, then surged by 174.66% to $8.7 million in 2025, then tumbled by 32.45% to $5.9 million in 2026.
- The last three Interest Expenses figures came in at $5.9 million (Q1 2026), $8.7 million (Q4 2025), and -$13.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Omeros | 737.87 Mn | 602.55 Mn | 9.31 Mn | 5.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.89 Mn |
| Mar 31, 2026 | 5.89 Mn |
| Dec 31, 2025 | 8.73 Mn |
| Dec 31, 2025 | 8.73 Mn |
| Sep 30, 2025 | -13.36 Mn |
| Sep 30, 2025 | -13.36 Mn |
| Jun 30, 2025 | 15,000.00 |
| Jun 30, 2025 | 15,000.00 |
| Mar 31, 2025 | 3.65 Mn |
| Mar 31, 2025 | 3.65 Mn |
| Dec 31, 2024 | 3.18 Mn |
| Dec 31, 2024 | 3.18 Mn |
| Sep 30, 2024 | 4.05 Mn |
| Sep 30, 2024 | 4.05 Mn |
| Jun 30, 2024 | 9.22 Mn |
| Jun 30, 2024 | 9.22 Mn |
| Mar 31, 2024 | 8.23 Mn |
| Mar 31, 2024 | 8.23 Mn |
| Dec 31, 2023 | 7.06 Mn |
| Dec 31, 2023 | 7.06 Mn |